Global Down Syndrome

Issue 2 of 4 - 2017

Issue link: http://viewer.e-digitaledition.com/i/842481

Contents of this Issue

Navigation

Page 8 of 31

OVER A 30-YEAR CAREER, ROGER REEVES, PH.D., PROFESSOR AT THE PRESTIGIOUS JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE IN THE DEPARTMENT OF PHYSIOLOGY AND THE MCKUSICK-NATHANS INSTITUTE OF GENETIC MEDICINE, HAS BECOME ONE OF THE FIELD'S MOST RESPECTED, KNOWLEDGEABLE RESEARCHERS. Moving Down Syndrome Research AFTER CONDUCTING HIS thesis research at the National Cancer Institute at the National Institutes of Health, Dr. Reeves joined Johns Hopkins researchers John Gearhart, Ph.D. (who would lead the first team to identify human embryonic stem cells), and John Littlefield, M.D. (an influential physician-scientist whose genetic mapping techniques contributed to the Human Genome Project). Dr. Reeves' initial goal was to develop a mouse model for Down syndrome with Dr. Gearhart, and he has spent a lifetime furthering Down syndrome research through investigations into its genetic underpinnings. EARLY INSIGHTS INTO DOWN SYNDROME GENETICS A breakthrough for Dr. Reeves came in the early 1990s, when researcher Muriel Davisson, Ph.D., developed the first genetic mouse model for Down syndrome, known as Ts65Dn. "She did an incredibly bold experiment that would never survive study section [a panel of scientists who review grant applications] today," Dr. Reeves said. "She was able to create translocations of mouse chromosomes so they rearranged, and mapped those microscopically using cytogenetics." Dr. Reeves used those mouse models to create his own Ts65Dn-like cells, and thanks to Dr. Littlefield's genetic mapping techniques, was able to compare genes on the newly created chromosome in mouse cells to those on human chromosome 21. The results of Dr. Reeves' and Dr. Davisson's collaboration, published in the October 1995 issue of Nature Genetics, revealed, for the first time, that certain genetic perturbations in mice produced outcomes that directly correlated with what happened in a person with extra copies of those genes. For example, changes in facial features, heart anomalies, and learning and memory deficits occur in both people with Down syndrome and the Ts65Dn mice. "This allowed us to change the way people thought about basic research in trisomy," Dr. Reeves said. His findings have played a major role in neuroscientific and neurobehavioral research into cognition. CONTINUED ON PAGE 10 FORWARD John J. Sie, Board Member of the Global Down Syndrome Foundation, with Roger Reeves Ph.D., Professor at Johns Hopkins University School of Medicine GLOBALDOWNSYNDROME.ORG 9 GLOBALDOWNSYNDROME.ORG 9

Articles in this issue

Archives of this issue

view archives of Global Down Syndrome - Issue 2 of 4 - 2017